한글목차

개요

목캔디(Throat Pastilles)와 코프 드롭(Cough Drops) 시장은 2023-2028년 12억 5,000만 달러, 예측 기간 중 CAGR은 3.72%로 성장할 것으로 예측되고 있습니다.

목캔디와 코프 드롭 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25개의 벤더를 다룬 벤더 분석 등을 제공합니다.

현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공하고 있습니다. 시장은 기타 제형에 대한 우위성, 호흡기 감염증의 증가, 노인 인구 기반의 확대 등에 의해 촉진되고 있습니다.

본 조사에서는 혁신적인 목캔디와 코프 드롭 로젠지의 출현을 향후 수년간 목캔디와 코프 드롭 시장의 성장을 촉진하는 주요 요인의 하나로 들고 있습니다. 또한 포장 기술 첨단화 및 유통망의 강화를 향한 벤더의 주력도 시장의 큰 수요로 연결될 것으로 전망됩니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 구도

• 시장 에코시스템

제3장 시장 규모

• 시장의 정의
• 시장 부문 분석
• 시장 규모 2023
• 시장 전망 2023-2028

제4장 시장 규모 실적

• 세계의 목캔디와 코프 드롭 시장 2018-2022
• 유형 부문 분석 2018-2022
• 최종사용자 부문 분석 2018-2022
• 지역별 부문 분석 2018-2022
• 국가별 부문 분석 2018-2022

제5장 Five forces 분석

• Five Forces 요약
• 구매자의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 현황

제6장 시장 세분화 : 유형별

• 시장 부문
• 비교 : 유형별
• 하드 태블릿 로젠지 : 시장 규모와 예측 2023-2028
• 소프트 태블릿 트로키 : 시장 규모와 예측 2023-2028
• 압축 정제 트로키 : 시장 규모와 예측 2023-2028
• 시장 기회 : 유형별

제7장 시장 세분화 : 최종사용자별

• 시장 부문
• 비교 : 최종사용자별
• 병원 : 시장 규모와 예측 2023-2028
• 클리닉 : 시장 규모와 예측 2023-2028
• 기타 : 시장 규모와 예측 2023-2028
• 시장 기회 : 최종사용자별

제8장 고객 상황

• 고객 상황의 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측 2023-2028
• 유럽 : 시장 규모와 예측 2023-2028
• 아시아 : 시장 규모와 예측 2023-2028
• 세계의 기타 지역 : 시장 규모와 예측 2023-2028
• 미국 : 시장 규모와 예측 2023-2028
• 독일 : 시장 규모와 예측 2023-2028
• 일본 : 시장 규모와 예측 2023-2028
• 영국 : 시장 규모와 예측 2023-2028
• 캐나다 : 시장 규모와 예측 2023-2028
• 시장 기회 : 지역 상황별

제10장 촉진요인, 과제 및 동향

• 시장 촉진요인
• 시장이 해결해야 할 과제
• 촉진요인과 과제의 영향
• 시장 동향

제11장 벤더 구도

• 개요
• 벤더 구도
• 혼란의 상황
• 업계의 리스크

제12장 벤더 분석

• 대상 벤더
• 벤더의 시장 포지셔닝
• Andre Prost Inc
• Aurobindo Pharma Ltd.
• Boyd Pharmaceuticals
• CVS Health Corp.
• FISHERMANSFRIEND.COM
• GRETHERS USA
• iNova Pharmaceuticals
• Johnson and Johnson
• Lanes Health
• Mondelez International Inc.
• PINE BROS LLC.
• Prestige Consumer Healthcare Inc.
• Procter and Gamble
• Reckitt Benckiser Group Plc
• Ricola Group AG

제13장 부록

영문목차

Abstract

The throat pastilles and cough drops market is forecasted to grow by USD 1.25 bn during 2023-2028, accelerating at a CAGR of 3.72% during the forecast period. The report on the throat pastilles and cough drops market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advantages over other dosage forms, increasing incidences of respiratory tract infections, and expanding geriatric population base driving the market for throat pastilles and cough drops.

Technavio's throat pastilles and cough drops market is segmented as below:

By Type

• Hard tablet lozenges
• Soft tablet lozenges
• Compressed tablet lozenges

By End-user

• Hospitals
• Clinics
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the emergence of innovative throat pastilles and cough drops lozenges as one of the prime reasons driving the throat pastilles and cough drops market growth during the next few years. Also, advancements in packaging techniques and growing focus of vendors toward enhancing distribution network will lead to sizable demand in the market.

The report on the throat pastilles and cough drops market covers the following areas:

• Throat pastilles and cough drops market sizing
• Throat pastilles and cough drops market forecast
• Throat pastilles and cough drops market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading throat pastilles and cough drops market vendors that include Andre Prost Inc, Aurobindo Pharma Ltd., Boyd Pharmaceuticals, CVS Health Corp., FISHERMANSFRIEND.COM, GRETHERS USA, iNova Pharmaceuticals, Johnson and Johnson, Lanes Health, Maneesh Pharmaceuticals Ltd, Mondelez International Inc., PINE BROS LLC., Prestige Consumer Healthcare Inc., Prince Care Pharma Pvt Ltd, Procter and Gamble, Quantum Health, Reckitt Benckiser Group Plc, Ricola Group AG, STADA Arzneimittel AG, and Walgreens Boots Alliance Inc.. Also, the throat pastilles and cough drops market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global throat pastilles and cough drops market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global throat pastilles and cough drops market 2018 - 2022 ($ billion)
• 4.2 Type Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
• 4.3 End-user Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

• 6.1 Market segments
• Exhibit 30: Chart on Type - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
• 6.2 Comparison by Type
• Exhibit 32: Chart on Comparison by Type
• Exhibit 33: Data Table on Comparison by Type
• 6.3 Hard tablet lozenges - Market size and forecast 2023-2028
• Exhibit 34: Chart on Hard tablet lozenges - Market size and forecast 2023-2028 ($ billion)
• Exhibit 35: Data Table on Hard tablet lozenges - Market size and forecast 2023-2028 ($ billion)
• Exhibit 36: Chart on Hard tablet lozenges - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Hard tablet lozenges - Year-over-year growth 2023-2028 (%)
• 6.4 Soft tablet lozenges - Market size and forecast 2023-2028
• Exhibit 38: Chart on Soft tablet lozenges - Market size and forecast 2023-2028 ($ billion)
• Exhibit 39: Data Table on Soft tablet lozenges - Market size and forecast 2023-2028 ($ billion)
• Exhibit 40: Chart on Soft tablet lozenges - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Soft tablet lozenges - Year-over-year growth 2023-2028 (%)
• 6.5 Compressed tablet lozenges - Market size and forecast 2023-2028
• Exhibit 42: Chart on Compressed tablet lozenges - Market size and forecast 2023-2028 ($ billion)
• Exhibit 43: Data Table on Compressed tablet lozenges - Market size and forecast 2023-2028 ($ billion)
• Exhibit 44: Chart on Compressed tablet lozenges - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Compressed tablet lozenges - Year-over-year growth 2023-2028 (%)
• 6.6 Market opportunity by Type
• Exhibit 46: Market opportunity by Type ($ billion)
• Exhibit 47: Data Table on Market opportunity by Type ($ billion)

7 Market Segmentation by End-user

• 7.1 Market segments
• Exhibit 48: Chart on End-user - Market share 2023-2028 (%)
• Exhibit 49: Data Table on End-user - Market share 2023-2028 (%)
• 7.2 Comparison by End-user
• Exhibit 50: Chart on Comparison by End-user
• Exhibit 51: Data Table on Comparison by End-user
• 7.3 Hospitals - Market size and forecast 2023-2028
• Exhibit 52: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
• Exhibit 53: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
• Exhibit 54: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
• 7.4 Clinics - Market size and forecast 2023-2028
• Exhibit 56: Chart on Clinics - Market size and forecast 2023-2028 ($ billion)
• Exhibit 57: Data Table on Clinics - Market size and forecast 2023-2028 ($ billion)
• Exhibit 58: Chart on Clinics - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Clinics - Year-over-year growth 2023-2028 (%)
• 7.5 Others - Market size and forecast 2023-2028
• Exhibit 60: Chart on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 61: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 62: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 63: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 7.6 Market opportunity by End-user
• Exhibit 64: Market opportunity by End-user ($ billion)
• Exhibit 65: Data Table on Market opportunity by End-user ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 69: Chart on Geographic comparison
• Exhibit 70: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
• Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 Japan - Market size and forecast 2023-2028
• Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.10 UK - Market size and forecast 2023-2028
• Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.11 Canada - Market size and forecast 2023-2028
• Exhibit 103: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
• Exhibit 104: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
• Exhibit 105: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibit 106: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 107: Market opportunity By Geographical Landscape ($ billion)
• Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 109: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 111: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 112: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 113: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 114: Matrix on vendor position and classification
• 12.3 Andre Prost Inc
• Exhibit 115: Andre Prost Inc - Overview
• Exhibit 116: Andre Prost Inc - Product / Service
• Exhibit 117: Andre Prost Inc - Key offerings
• 12.4 Aurobindo Pharma Ltd.
• Exhibit 118: Aurobindo Pharma Ltd. - Overview
• Exhibit 119: Aurobindo Pharma Ltd. - Product / Service
• Exhibit 120: Aurobindo Pharma Ltd. - Key offerings
• 12.5 Boyd Pharmaceuticals
• Exhibit 121: Boyd Pharmaceuticals - Overview
• Exhibit 122: Boyd Pharmaceuticals - Product / Service
• Exhibit 123: Boyd Pharmaceuticals - Key offerings
• 12.6 CVS Health Corp.
• Exhibit 124: CVS Health Corp. - Overview
• Exhibit 125: CVS Health Corp. - Business segments
• Exhibit 126: CVS Health Corp. - Key offerings
• Exhibit 127: CVS Health Corp. - Segment focus
• 12.7 FISHERMANSFRIEND.COM
• Exhibit 128: FISHERMANSFRIEND.COM - Overview
• Exhibit 129: FISHERMANSFRIEND.COM - Product / Service
• Exhibit 130: FISHERMANSFRIEND.COM - Key offerings
• 12.8 GRETHERS USA
• Exhibit 131: GRETHERS USA - Overview
• Exhibit 132: GRETHERS USA - Product / Service
• Exhibit 133: GRETHERS USA - Key offerings
• 12.9 iNova Pharmaceuticals
• Exhibit 134: iNova Pharmaceuticals - Overview
• Exhibit 135: iNova Pharmaceuticals - Product / Service
• Exhibit 136: iNova Pharmaceuticals - Key offerings
• 12.10 Johnson and Johnson
• Exhibit 137: Johnson and Johnson - Overview
• Exhibit 138: Johnson and Johnson - Business segments
• Exhibit 139: Johnson and Johnson - Key news
• Exhibit 140: Johnson and Johnson - Key offerings
• Exhibit 141: Johnson and Johnson - Segment focus
• 12.11 Lanes Health
• Exhibit 142: Lanes Health - Overview
• Exhibit 143: Lanes Health - Product / Service
• Exhibit 144: Lanes Health - Key offerings
• 12.12 Mondelez International Inc.
• Exhibit 145: Mondelez International Inc. - Overview
• Exhibit 146: Mondelez International Inc. - Business segments
• Exhibit 147: Mondelez International Inc. - Key news
• Exhibit 148: Mondelez International Inc. - Key offerings
• Exhibit 149: Mondelez International Inc. - Segment focus
• 12.13 PINE BROS LLC.
• Exhibit 150: PINE BROS LLC. - Overview
• Exhibit 151: PINE BROS LLC. - Product / Service
• Exhibit 152: PINE BROS LLC. - Key offerings
• 12.14 Prestige Consumer Healthcare Inc.
• Exhibit 153: Prestige Consumer Healthcare Inc. - Overview
• Exhibit 154: Prestige Consumer Healthcare Inc. - Business segments
• Exhibit 155: Prestige Consumer Healthcare Inc. - Key offerings
• Exhibit 156: Prestige Consumer Healthcare Inc. - Segment focus
• 12.15 Procter and Gamble
• Exhibit 157: Procter and Gamble - Overview
• Exhibit 158: Procter and Gamble - Business segments
• Exhibit 159: Procter and Gamble - Key offerings
• Exhibit 160: Procter and Gamble - Segment focus
• 12.16 Reckitt Benckiser Group Plc
• Exhibit 161: Reckitt Benckiser Group Plc - Overview
• Exhibit 162: Reckitt Benckiser Group Plc - Business segments
• Exhibit 163: Reckitt Benckiser Group Plc - Key offerings
• Exhibit 164: Reckitt Benckiser Group Plc - Segment focus
• 12.17 Ricola Group AG
• Exhibit 165: Ricola Group AG - Overview
• Exhibit 166: Ricola Group AG - Product / Service
• Exhibit 167: Ricola Group AG - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 168: Inclusions checklist
• Exhibit 169: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 170: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 171: Research methodology
• Exhibit 172: Validation techniques employed for market sizing
• Exhibit 173: Information sources
• 13.5 List of abbreviations
• Exhibit 174: List of abbreviations